Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
172M
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
91.8M
-
Shares change
-
+2.63M
-
Total reported value, excl. options
-
$2.89B
-
Value change
-
+$74.3M
-
Put/Call ratio
-
0.74
-
Number of buys
-
75
-
Number of sells
-
-43
-
Price
-
$31.53
Significant Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) as of Q3 2021
158 filings reported holding RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91.8M shares
of 172M outstanding shares and own 53.45% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (27.9M shares), FMR LLC (13.7M shares), BlackRock Inc. (5.35M shares), VANGUARD GROUP INC (4.88M shares), Bellevue Group AG (3.76M shares), Casdin Capital, LLC (3.67M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (3.05M shares), STATE STREET CORP (2.68M shares), BVF INC/IL (2.05M shares), and PERCEPTIVE ADVISORS LLC (1.94M shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.